Showing results (31-40 of 96) with videos related to
Sort By:
Pageof 10
Diabetologia|March 1, 1980
Platelet shape change abnormalities in diabetic retinopathyM Porta, P Hilgard, E M KohnerZeitschrift Fur Krebsforschung Und Klinische Onkologie. Cancer Research and Clinical Oncology|August 30, 1976
The influence of platelet aggregation inhibitors on metastasis formation in mice (3LL)P Hilgard, H Heller, C G SchmidtBiochemistry|September 1, 1981
Escherichia coli single-strand deoxyribonucleic acid binding protein: stability, specificity, and kinetics of complexes with oligonucleotides and deoxyribonucleic acidG Krauss, H Sindermann, U Schomburg, et al.Cancer Chemotherapy and Pharmacology|January 1, 1990
Protection from ifosfamide-induced alopecia by topical thiols in young ratsJ Stekar, P Hilgard, W Holtei, et al.Minerva Gastroenterologica E Dietologica|July 20, 2011
Locoregional therapy for hepatocellular carcinoma: radioembolization with yttrium-90 microspheresK Herzer, S Müller, G Antoch, et al.Archiv Der Pharmazie|October 1, 1991
Platelet aggregation inhibiting and anticoagulant effects of oligoamines, XVI: Cytostatic and cytotoxic side effects of oligoaminesK Rehse, B Noack, R Maurer, et al.Cancer Treatment Reviews|December 1, 1987
Anticancer drugs: estrophilic cisplatin derivativesJ Engel, H Schönenberger, F Lux, et al.European Journal of Biochemistry|August 1, 1995
Selection and characterization of mammalian cell lines with stable over-expression of human pituitary receptors for gonadoliberinT Beckers, K Marheineke, H Reiländer, et al.Journal of Cancer Research and Clinical Oncology|January 1, 1989
Evidence of a role for NK cells in oxazaphosphorine-mediated tumor regressionT Reissmann, P Hilgard, R Voegeli, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1989
Augmentation of host antitumor immunity by low doses of cyclophosphamide and mafosfamide in two animal tumor modelsT Reissmann, R Voegeli, J Pohl, et al.Pageof 10